Belpointe Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-328
Closed -$3.22K 1307
2023
Q1
$3.22K Buy
328
+58
+21% +$619 ﹤0.01% 3172
2022
Q4
$2.87K Buy
+270
New +$3.14K ﹤0.01% 3138
2020
Q3
Sell
-11,239
Closed -$100K 790
2020
Q2
$100K Buy
+11,239
New +$56.8K 0.01% 730

Other funds holding DVAX

Belpointe Asset Management's DVAX Position: Q2 2023 in Review

Belpointe Asset Management sold out of Dynavax Technologies (DVAX) in Q2 2023, closing a stake of 328 shares — an estimated $3.22K sold.

Belpointe Asset Management first reported a position in DVAX in Q2 2020 and held it in 3 quarters. The position peaked at $100K in Q2 2020. 215 funds tracked by Wall St. Rank hold DVAX as of Q2 2023.

  • Belpointe Asset Management reported no remaining Dynavax Technologies position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 328 Dynavax Technologies shares in Q2 2023, an estimated $3.22K.
  • Belpointe Asset Management first reported a position in Dynavax Technologies in Q2 2020 and held it in 3 quarters.
  • Belpointe Asset Management's Dynavax Technologies position peaked at $100K in Q2 2020.
  • 215 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.